Q2 Earnings Roundup: Record AUM at Mandatum, Revenue Acceleration at MDxHealth, Margin Gains at Rekor

The Quick Take

• Mandatum PLC (MANDF) reports record assets under management and strategic progress in its Q2 2026 earnings call
• MDxHealth SA (MDXH) achieves its largest quarter-over-quarter revenue acceleration while eliminating a $10.4 million liability
• Rekor Systems (REKR) posts 79% reduction in adjusted EBITDA loss as privacy scrutiny over ALPR technology persists

A diverse cluster of 25 Q2 2026 earnings reports highlights a broad cross-section of smaller US-listed companies navigating distinct operational environments. Mandatum PLC, the Finnish wealth management company listed in the US, reports record assets under management reflecting continued European private wealth accumulation even as equity market volatility persisted in H1 2026. MDxHealth, a Belgian diagnostics company focused on precision oncology urology tests, achieved its largest sequential revenue acceleration in company history while eliminating a $10.4 million financial liability through a strategic action, materially improving its balance sheet.

Rekor Systems' 79% reduction in adjusted EBITDA loss reflects the operational restructuring of a company building AI-powered infrastructure analytics and license plate recognition (ALPR) systems. The ALPR privacy scrutiny mentioned in the earnings highlights represents a regulatory and reputational risk that has constrained Rekor's market penetration speed despite demonstrable technology differentiation. SRX Global's 27% revenue increase and 52% cost reduction in Q3 2026 rounds out a pattern where technology-adjacent companies are using AI-driven efficiency to compress cost structures while maintaining or growing revenues — a validation of the broader AI-productivity thesis.

The composite picture across these 25 companies is one of divergent recovery: well-capitalized companies with strong product-market fit are showing accelerating revenue metrics, while those navigating regulatory, privacy, or cash-position constraints are improving incrementally but remain exposed to execution risk. Investors screening this cluster for common patterns should note that the strongest performers — Mandatum on AUM, MDxHealth on revenue — share the characteristic of a clear, defensible market position. Forward signals include Q3 guidance from each company and any capital structure actions that validate or undermine the balance sheet improvement narratives.

Synthesized from 25 sources.